NISA INVESTMENT ADVISORS, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$51,969
-20.0%
1,1300.0%0.00%
Q2 2023$64,941
+154521.4%
1,1300.0%0.00%
Q1 2023$42
+31.2%
1,1300.0%0.00%
Q4 2022$32
-99.9%
1,1300.0%0.00%
Q3 2022$35,000
-60.7%
1,130
-55.7%
0.00%
-100.0%
Q2 2022$89,000
+18.7%
2,550
+22.0%
0.00%0.0%
Q1 2022$75,000
-87.7%
2,090
-92.1%
0.00%
-80.0%
Q4 2021$612,000
+21.2%
26,485
-0.2%
0.01%
+66.7%
Q3 2021$505,000
-22.3%
26,547
-17.7%
0.00%
-25.0%
Q2 2021$650,000
+1.4%
32,264
-7.7%
0.00%0.0%
Q1 2021$641,000
-8.8%
34,9640.0%0.00%
-20.0%
Q4 2020$703,000
+115.0%
34,964
+100.7%
0.01%
+66.7%
Q3 2020$327,000
-58.1%
17,422
-49.9%
0.00%
-57.1%
Q2 2020$781,000
+88.2%
34,751
+24.3%
0.01%
+40.0%
Q1 2020$415,000
-23.0%
27,9530.0%0.01%0.0%
Q4 2019$539,000
+20.6%
27,953
+24.1%
0.01%
+25.0%
Q3 2019$447,000
-44.6%
22,530
-41.1%
0.00%
-50.0%
Q2 2019$807,000
+3.3%
38,2410.0%0.01%0.0%
Q1 2019$781,000
+242.5%
38,241
+233.4%
0.01%
+166.7%
Q4 2018$228,000
+3.2%
11,4700.0%0.00%
+50.0%
Q3 2018$221,00011,4700.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders